Literature DB >> 33950044

Musculoskeletal Injuries in US Air Force Security Forces, January 2009 to December 2018.

Julia N Sundstrom1, Bryant J Webber, George L Delclos, John R Herbold, David Gimeno Ruiz de Porras.   

Abstract

OBJECTIVE: To determine the incidence, types, and risk factors of musculoskeletal injuries in a military security forces population.
METHODS: Demographic and diagnostic data were retrieved on enlisted US Air Force security forces personnel who served on active duty between January 2009 and December 2018. Incidence rates and ratios were calculated using Poisson regression.
RESULTS: During 251,787 person-years of exposure, 62,489 personnel served on active duty. Of these, 40,771 (65.2%) were diagnosed with at least one musculoskeletal injury. The majority (60.1%) of the 164,078 unique musculoskeletal injuries were inflammation and pain secondary to overuse. After adjusting for other factors, women had a 31% higher injury rate than men, and those who were overweight and obese had 15% and 30% higher rates, respectively, than normal-weight peers.
CONCLUSIONS: Modifiable and non-modifiable factors contribute to musculoskeletal injuries in the security forces career field.

Entities:  

Mesh:

Year:  2021        PMID: 33950044      PMCID: PMC8607196          DOI: 10.1097/JOM.0000000000002207

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.306


  26 in total

Review 1.  Prevention of physical training-related injuries recommendations for the military and other active populations based on expedited systematic reviews.

Authors:  Steven H Bullock; Bruce H Jones; Julie Gilchrist; Stephen W Marshall
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

2.  Rationale for Embedded Musculoskeletal Care in Air Force Training and Operational Units.

Authors:  Nathaniel S Nye; Sarah J de la Motte
Journal:  J Athl Train       Date:  2016-09-29       Impact factor: 2.860

3.  Gender differences in the associations of body mass index, physical fitness and tobacco use with lower extremity musculoskeletal injuries among new US Army soldiers.

Authors:  Sheryl A Bedno; D Alan Nelson; Lianne M Kurina; Y Sammy Choi
Journal:  Inj Prev       Date:  2018-03-23       Impact factor: 2.399

4.  Morbidity burdens attributable to various illnesses and injuries, deployed active and reserve component service members, U.S. Armed Forces, 2019.

Authors: 
Journal:  MSMR       Date:  2020-05

5.  Musculoskeletal injuries description of an under-recognized injury problem among military personnel.

Authors:  Keith G Hauret; Bruce H Jones; Steven H Bullock; Michelle Canham-Chervak; Sara Canada
Journal:  Am J Prev Med       Date:  2010-01       Impact factor: 5.043

6.  The Association between Increased Body Mass Index and Overuse Injuries in Israel Defense Forces Conscripts.

Authors:  Netanel A Hollander; Aharon S Finestone; Victoria Yofe; Tarif Bader; Racheli Magnezi
Journal:  Obes Facts       Date:  2020-02-13       Impact factor: 3.942

7.  Illness and injury risk and healthcare utilization, United States Air Force battlefield airmen and security forces, 2000-2005.

Authors:  Diane Warha; Timothy Webb; Timothy Wells
Journal:  Mil Med       Date:  2009-09       Impact factor: 1.437

8.  Risk factors for musculoskeletal injuries for soldiers deployed to Afghanistan.

Authors:  Tanja C Roy; Joseph J Knapik; Bradley M Ritland; Nicole Murphy; Marilyn A Sharp
Journal:  Aviat Space Environ Med       Date:  2012-11

9.  Incidence of acute injuries, active component, U.S. Armed Forces, 2008-2017.

Authors:  Shauna Stahlman; Stephen B Taubman
Journal:  MSMR       Date:  2018-07

10.  Diagnoses and factors associated with medical evacuation and return to duty for service members participating in Operation Iraqi Freedom or Operation Enduring Freedom: a prospective cohort study.

Authors:  Steven P Cohen; Charlie Brown; Connie Kurihara; Anthony Plunkett; Conner Nguyen; Scott A Strassels
Journal:  Lancet       Date:  2010-01-23       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.